BAALC and acute myeloid leukemia: The gene brain and acute leukemia, cytoplasmic (BAALC) has been suggested as a suitable MRD marker as it is expressed at low levels in peripheral blood and bone marrow of healthy individuals [14, 15], but upregulated in AML patients [15].